Completed OBSERVATIONAL NCT04351100

Efficacy of Diacerein on Ocular Surface Disease in Degenerative Arthritis Patients

Sponsor: Chulalongkorn University

Conditions Diacerein Ocular Surface Disease Osteoarthritis

Interventions Diacerein

Updated 7 times since 2020 Last updated: Aug 9, 2021 Started: Oct 1, 2019 Primary completion: Jul 31, 2020 Completion: Jul 31, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04351100, this observational or N/A phase trial focuses on Diacerein and Ocular Surface Disease and remains completed. Sponsored by Chulalongkorn University, it has been updated 7 times since 2019, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Dec 2021 — Jul 2024 [monthly]

Completed
Sep 2021 — Dec 2021 [monthly]

Completed

Status: Recruiting → Completed
Jan 2021 — Sep 2021 [monthly]

Recruiting

▶ Show 2 earlier versions

Nov 2020 — Jan 2021 [monthly]

Recruiting
May 2020 — Nov 2020 [monthly]

Recruiting

First recorded

Oct 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Chulalongkorn University

Data source: Chulalongkorn University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bangkok, Thailand